Cachexia therapeutics

E. Therapeutic response Significant reductions in hepatosplenomegaly, improvement in hematologic deficiencies, and decreased cachexia have been reported with long-term Cerezyme therapy in patients with type 1 Gaucher s disease. Symptomatic improvement occurs within 6 months of induction of therapy. Serum hemoglobin and platelet values decrease to near-baseline values within 6 months of discontinuation of therapy. 

Inui A. Cancer anorexia-cachexia syndrome are neuropeptides the key Cancer Res 1999 59 449.1-4501. Johnson D, Drenick EJ. Therapeutic fasting in morbid obesity. Arch Int Med 1977 137 1381-1382. 

The potential role of SARMs in the treatment of cancer cachexia and weight loss focuses again on the building of muscle mass. This therapeutic indication stands as... 

For the above retisons, and probably others yet unknown, cancer patients often exhibit cachexia—a general lack of nutrition. Hence, steps should be taken to correct the malnutrition and fluid and electrolyte imbalances in order for other therapeutic measures to proceed—and succeed. 

---